SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma begins sale of compulsorily licensed drug- Nexavar

09 Jul 2012 Evaluate

Pharmaceutical company, Natco Pharma, has begun the sale of its first compulsorily licensed drug, which is the generic version of Bayer's Nexavar. The drug, which is used for the treatment of advanced kidney cancer, is priced at Rs 8,880 for a pack of 120 tablets. The company is expecting to add about Rs 15 crore revenue from this drug initially.

In a major blow, Natco Pharma recently lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug - Copaxone.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets. The company began its operations in 1984 in Andhra Pradesh.

Natco Pharma Share Price

1208.75 34.75 (2.96%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×